ReviewCurrent genomics2025
Role of Long Noncoding RNA Dio3os in Glycolipid Metabolism.
Review in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The roles and clinical significance of LINC01140 in human cancers in the real world.Cell division · 2026Review
- LncRNA AFAP1-AS1 mediates therapy-dependent expression of CCL5, CXCL10 and MMP9 in multiple sclerosis.Biochemistry and biophysics reports · 2026Article
- Dynamic Metabolic States in TNBC: Orchestrating Spatiotemporal Adaptation and Therapy.Oncology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recent investigations have underscored the importance of long non-coding RNAs (lncRNAs), which exhibit more specific expression in tissues and cells than mRNA and are involved in gene regulation during development, pathology, and other processes through various mechanisms. Despite the predominant focus on the role of lncRNA Dio3os in cancer research, there has been relatively limited exploration of its potential involvement in glycolipid metabolism. Therefore, this study aims to consolidate existing knowledge on the function of Dio3os in glycolipid metabolism and calls for a broader investigation into its physiological roles. Methods: This review synthesizes available literature to detail the gene characteristics of lncRNA Dio3os and its expression patterns. It also compiles recent insights and mechanisms pertaining to Dio3os's involvement in glycolipid metabolism, particularly its participation in the ceRNA regulatory network. Results: Recent studies demonstrate that lncRNA Dio3os regulates glycolysis in cancer cells and impacts obesity, potentially serving as an indicator for diabetic peripheral neuropathy. Furthermore, its diminished expression has been noted in atherosclerotic plaques. Conclusion: lncRNA Dio3os exerts a significant regulatory influence on glycolipid metabolism, with variations in its expression levels potentially affecting disease presentations. Further investigations are warranted to elucidate the precise relationship between lncRNA Dio3os and its associated pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.